These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20501847)

  • 1. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.
    Glondu-Lassis M; Dromard M; Lacroix-Triki M; Nirdé P; Puech C; Knani D; Chalbos D; Freiss G
    Cancer Res; 2010 Jun; 70(12):5116-26. PubMed ID: 20501847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation.
    Dromard M; Bompard G; Glondu-Lassis M; Puech C; Chalbos D; Freiss G
    Cancer Res; 2007 Jul; 67(14):6806-13. PubMed ID: 17638892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers.
    Vermeer PD; Bell M; Lee K; Vermeer DW; Wieking BG; Bilal E; Bhanot G; Drapkin RI; Ganesan S; Klingelhutz AJ; Hendriks WJ; Lee JH
    PLoS One; 2012; 7(1):e30447. PubMed ID: 22279592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPN13/PTPL1: an important regulator of tumor aggressiveness.
    Freiss G; Chalbos D
    Anticancer Agents Med Chem; 2011 Jan; 11(1):78-88. PubMed ID: 21235435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer.
    Révillion F; Puech C; Rabenoelina F; Chalbos D; Peyrat JP; Freiss G
    Int J Cancer; 2009 Feb; 124(3):638-43. PubMed ID: 19004008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells.
    Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
    Breast Cancer Res; 2019 May; 21(1):66. PubMed ID: 31113450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling.
    Wang J; Li S; Zhang X; Zhu N; Yiminniyaze R; Dong L; Li C; Gulinuer W; Xia J; Li J; Zhou D; Liu X; Zhang Y; Zhang Y; Li S
    Thorac Cancer; 2022 Nov; 13(21):3042-3051. PubMed ID: 36193770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
    Long Q; Sun J; Lv J; Liang Y; Li H; Li X
    Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
    Zhu JH; Chen R; Yi W; Cantin GT; Fearns C; Yang Y; Yates JR; Lee JD
    Oncogene; 2008 Apr; 27(18):2525-31. PubMed ID: 17982484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTPL1 and PKCδ contribute to proapoptotic signalling in prostate cancer cells.
    Castilla C; Chinchón D; Medina R; Torrubia FJ; Japón MA; Sáez C
    Cell Death Dis; 2013 Apr; 4(4):e576. PubMed ID: 23559010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells.
    Bompard G; Puech C; Prébois C; Vignon F; Freiss G
    J Biol Chem; 2002 Dec; 277(49):47861-9. PubMed ID: 12354757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp.
    Pichot CS; Arvanitis C; Hartig SM; Jensen SA; Bechill J; Marzouk S; Yu J; Frost JA; Corey SJ
    Cancer Res; 2010 Nov; 70(21):8347-56. PubMed ID: 20940394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1.
    Abaan OD; Hendriks W; Uren A; Toretsky JA; Erkizan HV
    Exp Cell Res; 2013 Jan; 319(1):1-11. PubMed ID: 23018179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle.
    Zhang Y; Tu Y; Zhao J; Chen K; Wu C
    J Cell Biol; 2009 Mar; 184(6):785-92. PubMed ID: 19307596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells.
    Castilla C; Flores ML; Conde JM; Medina R; Torrubia FJ; Japón MA; Sáez C
    Clin Exp Metastasis; 2012 Apr; 29(4):349-58. PubMed ID: 22274591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma.
    Han X; Xue L; Zhou L; Gong L; Zhu S; Yao L; Wang S; Lan M; Li Y; Zhang W
    Exp Mol Pathol; 2013 Dec; 95(3):270-5. PubMed ID: 23906871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells.
    Vultur A; Buettner R; Kowolik C; Liang W; Smith D; Boschelli F; Jove R
    Mol Cancer Ther; 2008 May; 7(5):1185-94. PubMed ID: 18483306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
    Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
    Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and Significance of PTPL1 in Hematological Malignancies].
    Wang WM; Wang J; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1744-7. PubMed ID: 25543508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness.
    Hamyeh M; Bernex F; Larive RM; Naldi A; Urbach S; Simony-Lafontaine J; Puech C; Bakhache W; Solassol J; Coopman PJ; Hendriks WJAJ; Freiss G
    Theranostics; 2020; 10(3):1016-1032. PubMed ID: 31938048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.